HMGB1 is released from necrotic cells or activated macrophages / dendritic cells. Extracellular HMGB1 acts as a DAMP molecule, a SASP component, or an immunosuppressive molecule. It associates with various pathologies such as cancer, sepsis, arteriosclerosis, chronic rheumatoid arthritis and nephritis.
arigo is the global leader of HMGB1 products and offers protein, neutralizing antibody , and ELISA kits to facilitate the functional studies of extracellular HMGB1.
|